Professional Compounding Centers of America
Compounding Pharmacy Supplier/Provider
Based in TX
AI Overview
With $910K in lobbying spend across 22 quarterly filings, Professional Compounding Centers of America is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2020 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $200K |
| 2021 | $200K |
| 2022 | $160K |
| 2023 | $160K |
| 2024 | $160K |
| 2025 | $30K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Professional Compounding Centers of America disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Pharmacy, Health Issues
Issues related to the Drug Quality and Security Act, Compounding Pharmacy, Reimbursement, and Patient Access.
HR. 748, Coronavirus Aid, Relief and Economic Security (CARES Act); issues related to drug supply chain and drug shortages
Medicare Part D reimbursement of bulk drug substances.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.